EP1979244A2 - Metallized packaging blister container - Google Patents
Metallized packaging blister containerInfo
- Publication number
- EP1979244A2 EP1979244A2 EP06848703A EP06848703A EP1979244A2 EP 1979244 A2 EP1979244 A2 EP 1979244A2 EP 06848703 A EP06848703 A EP 06848703A EP 06848703 A EP06848703 A EP 06848703A EP 1979244 A2 EP1979244 A2 EP 1979244A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- film
- blister
- metallized
- container
- micron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000004806 packaging method and process Methods 0.000 title claims abstract description 23
- 239000004800 polyvinyl chloride Substances 0.000 claims abstract description 182
- 229920000915 polyvinyl chloride Polymers 0.000 claims abstract description 178
- 239000010410 layer Substances 0.000 claims abstract description 111
- 239000012044 organic layer Substances 0.000 claims abstract description 31
- 239000000758 substrate Substances 0.000 claims abstract description 27
- 230000015572 biosynthetic process Effects 0.000 claims description 184
- 238000005755 formation reaction Methods 0.000 claims description 184
- 238000000034 method Methods 0.000 claims description 154
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 100
- 229910052782 aluminium Inorganic materials 0.000 claims description 100
- 239000004411 aluminium Substances 0.000 claims description 99
- 238000001771 vacuum deposition Methods 0.000 claims description 49
- 239000004922 lacquer Substances 0.000 claims description 28
- 239000000126 substance Substances 0.000 claims description 21
- 230000008569 process Effects 0.000 claims description 20
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 15
- 229920001684 low density polyethylene Polymers 0.000 claims description 15
- 239000004702 low-density polyethylene Substances 0.000 claims description 15
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 15
- 229940127557 pharmaceutical product Drugs 0.000 claims description 15
- 229920001903 high density polyethylene Polymers 0.000 claims description 13
- 239000004700 high-density polyethylene Substances 0.000 claims description 13
- 239000002131 composite material Substances 0.000 claims description 12
- 238000001465 metallisation Methods 0.000 claims description 12
- 238000003856 thermoforming Methods 0.000 claims description 11
- 229910052751 metal Inorganic materials 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 5
- 239000000049 pigment Substances 0.000 claims description 5
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- 229910001369 Brass Inorganic materials 0.000 claims description 2
- 229910000906 Bronze Inorganic materials 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
- 239000010951 brass Substances 0.000 claims description 2
- 239000010974 bronze Substances 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 claims description 2
- 238000007772 electroless plating Methods 0.000 claims description 2
- 238000009713 electroplating Methods 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 150000002739 metals Chemical class 0.000 claims description 2
- 238000010422 painting Methods 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 238000011179 visual inspection Methods 0.000 abstract description 43
- 230000004888 barrier function Effects 0.000 abstract description 22
- 235000013305 food Nutrition 0.000 abstract description 8
- 238000001782 photodegradation Methods 0.000 abstract description 7
- 239000010408 film Substances 0.000 description 370
- 239000003826 tablet Substances 0.000 description 79
- 239000011888 foil Substances 0.000 description 67
- 239000000047 product Substances 0.000 description 66
- 238000012856 packing Methods 0.000 description 45
- 238000007689 inspection Methods 0.000 description 42
- 239000000463 material Substances 0.000 description 40
- 239000002775 capsule Substances 0.000 description 36
- 238000003475 lamination Methods 0.000 description 36
- 229920003023 plastic Polymers 0.000 description 33
- 239000004033 plastic Substances 0.000 description 30
- 239000000203 mixture Substances 0.000 description 27
- 238000009472 formulation Methods 0.000 description 26
- 239000003814 drug Substances 0.000 description 18
- 229940079593 drug Drugs 0.000 description 16
- 239000002552 dosage form Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 229910001868 water Inorganic materials 0.000 description 15
- 230000005540 biological transmission Effects 0.000 description 14
- 238000000576 coating method Methods 0.000 description 13
- 239000004014 plasticizer Substances 0.000 description 13
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 12
- 229960001618 ethambutol hydrochloride Drugs 0.000 description 12
- 239000006185 dispersion Substances 0.000 description 11
- 238000007789 sealing Methods 0.000 description 11
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 10
- 239000011248 coating agent Substances 0.000 description 10
- 239000005033 polyvinylidene chloride Substances 0.000 description 10
- 239000005030 aluminium foil Substances 0.000 description 9
- 239000011104 metalized film Substances 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 8
- 239000004713 Cyclic olefin copolymer Substances 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 8
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000007937 lozenge Substances 0.000 description 8
- 239000000654 additive Substances 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 239000012674 herbal formulation Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 239000002245 particle Substances 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 230000002238 attenuated effect Effects 0.000 description 4
- 229960003405 ciprofloxacin Drugs 0.000 description 4
- 230000000593 degrading effect Effects 0.000 description 4
- 238000000151 deposition Methods 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 229960001597 nifedipine Drugs 0.000 description 4
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 4
- 229960005489 paracetamol Drugs 0.000 description 4
- 229910052814 silicon oxide Inorganic materials 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- -1 block Substances 0.000 description 3
- 239000011111 cardboard Substances 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000009512 pharmaceutical packaging Methods 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920006254 polymer film Polymers 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 238000001429 visible spectrum Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000887125 Chaptalia nutans Species 0.000 description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 238000007765 extrusion coating Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229940097275 indigo Drugs 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- 239000008297 liquid dosage form Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- XLFWDASMENKTKL-UHFFFAOYSA-N molsidomine Chemical compound O1C(N=C([O-])OCC)=C[N+](N2CCOCC2)=N1 XLFWDASMENKTKL-UHFFFAOYSA-N 0.000 description 2
- 229960004027 molsidomine Drugs 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000004447 silicone coating Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 238000007666 vacuum forming Methods 0.000 description 2
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- SKABKOZWEXUJTB-UHFFFAOYSA-N CCCCCCCCC1SC1CCCCCCC(CCS)C(O)=O Chemical compound CCCCCCCCC1SC1CCCCCCC(CCS)C(O)=O SKABKOZWEXUJTB-UHFFFAOYSA-N 0.000 description 1
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229910003087 TiOx Inorganic materials 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 238000007754 air knife coating Methods 0.000 description 1
- 229940062527 alendronate Drugs 0.000 description 1
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 1
- 229960002535 alfacalcidol Drugs 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- PZZYQPZGQPZBDN-UHFFFAOYSA-N aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229960000528 amlodipine Drugs 0.000 description 1
- HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 description 1
- 229910000410 antimony oxide Inorganic materials 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000011127 biaxially oriented polypropylene Substances 0.000 description 1
- 229920006378 biaxially oriented polypropylene Polymers 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- VQLYBLABXAHUDN-UHFFFAOYSA-N bis(4-fluorophenyl)-methyl-(1,2,4-triazol-1-ylmethyl)silane;methyl n-(1h-benzimidazol-2-yl)carbamate Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1.C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 VQLYBLABXAHUDN-UHFFFAOYSA-N 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 235000019241 carbon black Nutrition 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000005025 cast polypropylene Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- JOPOVCBBYLSVDA-UHFFFAOYSA-N chromium(6+) Chemical compound [Cr+6] JOPOVCBBYLSVDA-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013039 cover film Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229920006225 ethylene-methyl acrylate Polymers 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 238000003682 fluorination reaction Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000005001 laminate film Substances 0.000 description 1
- 239000002650 laminated plastic Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
- 229960001571 loperamide Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000009740 moulding (composite fabrication) Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000001053 orange pigment Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- VTRUBDSFZJNXHI-UHFFFAOYSA-N oxoantimony Chemical compound [Sb]=O VTRUBDSFZJNXHI-UHFFFAOYSA-N 0.000 description 1
- 229920006280 packaging film Polymers 0.000 description 1
- 239000012785 packaging film Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000004634 thermosetting polymer Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B27/00—Layered products comprising a layer of synthetic resin
- B32B27/06—Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material
- B32B27/08—Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material of synthetic resin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B27/00—Layered products comprising a layer of synthetic resin
- B32B27/30—Layered products comprising a layer of synthetic resin comprising vinyl (co)polymers; comprising acrylic (co)polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B27/00—Layered products comprising a layer of synthetic resin
- B32B27/30—Layered products comprising a layer of synthetic resin comprising vinyl (co)polymers; comprising acrylic (co)polymers
- B32B27/304—Layered products comprising a layer of synthetic resin comprising vinyl (co)polymers; comprising acrylic (co)polymers comprising vinyl halide (co)polymers, e.g. PVC, PVDC, PVF, PVDF
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/325—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil
- B65D75/327—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil and forming several compartments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G2205/00—General identification or selection means
- A61G2205/20—Color codes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B38/00—Ancillary operations in connection with laminating processes
- B32B2038/0052—Other operations not otherwise provided for
- B32B2038/0092—Metallizing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2307/00—Properties of the layers or laminate
- B32B2307/40—Properties of the layers or laminate having particular optical properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2327/00—Polyvinylhalogenides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2327/00—Polyvinylhalogenides
- B32B2327/06—PVC, i.e. polyvinylchloride
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2439/00—Containers; Receptacles
- B32B2439/70—Food packaging
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2439/00—Containers; Receptacles
- B32B2439/80—Medical packaging
Definitions
- the present invention relates to containers.
- this invention relates to pharmaceutical containers.
- pharmaceutical or pharmaceutical product used in this specification is deemed to include any form of tablet, capsule, ampoule, granule, liquid dosage form, pellet, slab, block, ball, condom , whether or not the product has pharmacological activity.
- a blister pack consists of a flat backing sheet called as “lid”, generally of cardboard, plastic or metal foil; and a base having a formed plastic "bubble” or “blister” , generally of transparent plastic, the backing sheet and blister being joined to form a sealed cavity in which the product rests.
- the lid is made of aluminium foil or an aluminium foil laminate.
- Aluminium foil is a material of choice for the lids on blister packs, as the thickness of the material used requires relatively little force for it to break. Consequently, the energy for rupture is low as aluminium is non-elastic.
- the base of the blister pack is made of polymeric material such as polyvinyl chloride (PVC), polyamides, polyolei ⁇ n, polyesters and laminates or multi-layered materials containing at least one of these materials and, if desired, aluminium foil.
- blister packs feature a base, which is covered by a lid foil.
- the lid foil may cover the whole of the base area and is usefully provided with a line of weakness in the region of each recess, or each recess may be covered with an individual lid segment. Within the line of weakness or on each lid segment may be a tab for gripping which enables the individual FIELD OF INVENTION
- the present invention relates to containers.
- this invention relates to pharmaceutical containers.
- pharmaceutical or pharmaceutical product used in this specification is deemed to include any form of tablet, capsule, ampoule, granule, liquid dosage form, pellet, slab, block, ball, condom , whether or not the product has pharmacological activity.
- a blister pack consists of a flat backing sheet called as “lid”, generally of cardboard, plastic or metal foil; and a base having a formed plastic "bubble” or “blister” , generally of transparent plastic, the backing sheet and blister being joined to form a sealed cavity in which the product rests.
- the lid is made of aluminium foil or an aluminium foil laminate.
- Aluminium foil is a material of choice for the lids on blister packs, as the thickness of the material used requires relatively little force for it to break. Consequently, the energy for rupture is low as aluminium is non-elastic.
- the base of the blister pack is made of polymeric material such as polyvinyl chloride (PVC), polyamides, polyolefin, polyesters and laminates or multi-layered materials containing at least one of these materials and, if desired, aluminium foil.
- blister packs feature a base, which is covered by a lid foil.
- the lid foil may cover the whole of the base area and is usefully provided with a line of weakness in the region of each recess, or each recess may be covered with an individual lid segment. Within the line of weakness or on each lid segment may be a tab for gripping which enables the individual
- the base and the lid are of the above-mentioned materials, whereby plastic laminates may also be employed for the lid materials.
- Blister packaging is formed in one of three ways.
- the blister package comprises a single moulded plastics sheet adapted to be folded along a central region.
- a blister or recess or protrusion
- the two blisters are aligned to form a single storage region.
- the plastics sheet is otherwise generally planar. The product to be sold is for convenience usually located within the blister prior to folding of the plastics sheet.
- a second method commonly known as captive blister packaging, comprises a planar sheet of plastics material into which a blister (or recess or protrusion) is formed, and held between a front and a back sheet of cardboard, the front sheet being provided with an opening through which the blister (but not the surrounding planar region of the plastics sheet) extends.
- the blister pack comprises a planar sheet of plastic material into which a blister is formed by hot stamping, air force, cold forming or vacuum suction method.
- the product to be packed is inserted in the blister and the base having blister is then sealed by a lid of plastics, laminates or aluminium foil.
- Pharmaceutical blisters as packaging for pharmaceutical formulations serve to package tablets, capsules or other forms of pharmaceuticals; safely and protect them from external environmental influences which might in certain circumstances affect the pharmaceutical quality of the formulations.
- water or water vapour should be mentioned in particular. If water penetrates into the interior of a blister it may cause lasting changes to the pharmaceutical quality of the drug stored therein. There is also the danger that volatile substances will diffuse out of the material contained in the blister during storage and thereby alter the pharmaceutical formulation.
- the blisters must be so designed that the atmospheric conditions inside them remain constant, e.g., in respect of inhalable preparations, so as not to alter their particle size distribution.
- the blister portion of the packaging may be formed by thermoforming or cold forming a region of a planar plastic material to a desired shape, e.g., by placing the plastic material between a pair of male and female dies that are temperature controlled at a temperature sufficient to soften the plastic and pressing the male and female dies together to form an indentation or "blister" in the plastic.
- a rolled polymeric web supplies the blister material.
- the film is plasticized by contact heaters.
- the contact heaters can be adjusted for precise plasticization of the film by controlling the temperature, contact pressure, and heating time. By directly monitoring energy consumption, only the film is heated and not the surrounding machine or environment. Once the critical plasticization temperature is reached, the film web is fed along the conveyor rollers into the forming station.
- the web is then thermoformed in a pressurized diaphragm station where the edges of the web are gripped and pulled taunt. Compressed air is then injected at critical points along the web, which correspond to the respective cavity placement sites.
- the cavities are formed as the PVC web sheet is drawn into the cavity moulds of the thermoforming chambers by means of the compressed air. Precisely engineered moulds create blister cavities that are uniform in size and thickness.
- the multi-blistered web is then transferred to the filling station where the product to be packaged can either be manually deposited within each cavity or as is more often the case, automatically placed therein using automated feeder tubes.
- the filled yet open blister packs continue onward to a foil sealing station wherein the lidding foil is fed into the machine and sealed onto the thermoformed web.
- a sealing roller with bores corresponding to the cavities of the web indexes and transports the PVC blister web through the sealing station at which point the heating roller fuses the lidding foil to the web thereby sealing the cavities closed.
- the filled and sealed web is embossed, perforated and then cut to the appropriate sized package so that unit doses can be removed from the main package without having to remove the tablet from the package until it is ready to be taken. Pressure is exerted against the blister cavity and the product is pushed through the foil cover.
- the movement of the web through the cavity forming, heating and sealing stations is intermittent. Movement of the web through the filling station however, is continuous and therefore there is a chance that the products can either be improperly disposed within the cavity or more than one may be placed therein. Such aberrations are unacceptable in large- scale commercial operations and there is therefore a need to detect when improperly filled packages occur.
- the cold-forming process is an intermittent process, and does not use heat for forming the cavities.
- the foil is shaped and moulded around a plug assist to form a cavity, using air pressure, typically of 7 bars, in the first stages of its operation, which is followed by product filling & sealing of Aluminium lid foil at temperatures of 180 to 200 deg. C, in the subsequent stages of its operation.
- the typical machine speed in (cycles per minute) of the m/c ranges from 20 to 25 cycles per minute. As such, it is a marginally more expensive process than thermoforming, and its tooling is a bit more expensive than that of thermo formers.
- the Cold Forming material structure does not form easily, so blister cavity designs cannot be too sharp, because the foil would then break.
- the Cold forming process ensures that the material is stretched uniformly and does not have localized stretching built into the design of the cavity.
- Vacuum thermoforming forming is a Continuous process that involves forming thermoplastic sheets into three-dimensional shapes through the application of heat and pressure. Basically during vacuum thermoforming forming processes, plastic material is heated until it becomes pliable, and then it is placed over a mould and drawn in by a vacuum until it takes on the desired shape.
- thermoforming process a sheet of heated plastic material is placed over a male or female mould.
- the typical forming temperatures range from 140 to 160 deg C.
- the application of a vacuum draws out the air between the mould and the sheet so that the plastic conforms to the mould exactly. This is accomplished through venting holes in the mould that are joined to vacuum lines.
- the mould also has a water cooling system integrated into it that brings the temperature of the plastic to the set temperature needed. When the curing temperature is reached and the piece is formed, air blows back into the mould and separates the new part from the mould. This is further followed by product filling and sealing in temperature ranges of 165 to 200 deg. C.
- the machine speeds ( in cycle/min.) is around 4 to 5 meters per minute, which translates to 80-100 blisters /min.
- High speed m/c's can deliver upto 700-800 blisters/min. depending on the blister sizes & no. of ups .
- Vacuum forming involves fewer parts and tooling than injection moulding, there is great design flexibility available, from a variety of prototypes to custom made designs that can be used to cover almost any product.
- United States Patent No. 4,039,080 is directed towards a tray having individual compartments for holding pills, capsules, or similar solid medication, each compartment being rectangular in plane view and arranged in a rectangular format or seven columns and a plurality of rows.
- the tray may be loaded with a week's medication for an individual patient with indicia adjacent each column indicating the day of the week, and indicia adjacent the rows indicating the time of day that the medication in each compartment is to be taken.
- a lid or cover cooperates with the wall means defining the individual compartments to mutually isolate the compartments when in the closed position.
- the inner surfaces of the compartments are preferably rounded in at least one plane of ease of withdrawing medication therefrom.
- This packaging system only gives a convenient way to pack but does not provide good moisture and gas barrier.
- Preferred blisters consist of transparent or at least translucent plastics or a base foil of transparent plastics and a cover foil of aluminium. Both foils may be laminates, i.e., they may consist of a number of foils of different materials.
- the blisters known from the prior art do not necessarily adequately protect a formulation embedded therein from the penetration of substances from outside such as, for example, gases or vapours, particularly oxygen, carbon dioxide, water vapour and solvents, even when they are mechanically intact. Theoretically, these substances may permeate or diffuse through the topside of the blister (cover foil), the underside (base foil) or through the seam between the cover foil and base foil.
- United States Patent Application No. 20050061705 relates to a new pharmaceutical blister with reduced permeability to water vapour and gas. This application teaches the coating of conventional blisters with a silicon oxide-containing functional layer to protect against gases, water vapour and organic molecules. This process is expensive and time consuming.
- United States Patent No. 4,593,515 discloses the use of an electronic sensor, which is positioned under the conveyor belt of a wrapping machine. Articles dropped from the conveyor path fall upon the sensor, which not only catches the articles but also generates a stop signal, which stops the conveyor belt so the article may be retrieved and placed back on the belt.
- United States Patent No. 5,040,353 to Evans et. al. also discloses a blister packing process whereby a sensor apparatus includes a plurality of air valves for removing empty blister cavities prior to sealing.
- the cavities pass through a detection station, which sends a signal to the pneumatic air valves upon sensing an empty blister packet. This ignites a high- pressure airflow, which selectively separates the unfilled, empty blister cavities from the filled packs, which are ready for sealing.
- United States Patent No. 4,472,922 to Romagnoli teaches a system for monitoring a blister packaging machine comprising a photosensitive detector device, which scans the blister pack carrier strip, and upon sensing an empty blister cavity activates a perforator that punches a hole into the cover strip comprising the empty blisters.
- An error pulse simultaneously loaded into a shift register actuates, after a suitable delay, a sorter downstream of the cutting station that eliminates the defective blister package from the regular machine output.
- United States Patent No. 6,757,420 is concerned' with the problem of providing an automatic inspection device, with which it is possible to determine, with little effort and without contact, whether packages, particularly sealed blister packages consisting of a blister container and a cover film, are free of defects.
- This problem is solved by the use of at least two light sources, which are arranged at a certain distance from one another and each emit a light bundle at a predetermined wavelength range, whereby the emission maxima of the two light sources are offset in relation to one another.
- the light sources are arranged such that the packages are vertically illuminated.
- a CCD camera records the light reflected by the packages and the digital images are stored in a computer, so that they are available in a computer-supported image-processing and documentation system.
- United States Patent No. 5,555,707 discloses a blister pack scanning device for detection and removal of overfilled or defective pharmaceutical blister packs is comprised of a photoelectric LED transmitter and sensor with a scanning beam channel bar disposed there between.
- the blister pack web is passed below the bar through a space precisely equivalent to the thickness of a properly filled blister. Overfilled or improperly moulded blisters will contact a bevelled edge of the bar as the web passes thereunder and the lateral movement forces the bar and its two end plates which are in juxtaposition to the transmitter and receiver respectively, to move upward, thereby interfering with the beams transmission. The interference created thereby shuts off the blister production machine and sounds an alarm for removal of the defective package.
- Polyvinyl chloride is a relatively inexpensive packaging material but has little use in the blister packaging of sensitive drugs because of its poor moisture barrier properties.
- Plain PVC in flat film form in the thickness range of 100 to 400 microns has an MVTR [moisture vapour transmission rate] of 3-4 g/m 2 /24 hr.
- MVTR moisture vapour transmission rate
- thermo or cold formed this typically increases to between 15 to 20 g/m 2 /24 hr.
- the packing created by using normal PVC film can be copied easily by any manufacturer, as it is cheaply available and therefore can be counterfeited.
- manufacture of PVC film in the prior art involves the use of various additives such as mordents and accelerators and non-food grade plasticizers, which renders the PVC unsuitable for the pharmaceutical applications.
- various additives such as mordents and accelerators and non-food grade plasticizers, which renders the PVC unsuitable for the pharmaceutical applications.
- For pharmaceutical use only food/pharmaceutical grade can be used.
- these prior art films cannot be thermoformed easily and hence cannot be applicable for blister packaging applications.
- Plasticizers are substances added to plastic compounds to improve their flexibility, extensibility and process ability. It is characteristic of plasticizer substances that they lower the melting temperature, elastic modulus and second order transaction temperature of polymers but do not alter the chemical nature of the micro molecules. By varying the concentration of plasticizers one can vary the desirable application properties of polymers. Plasticizers can be classified as re primary plasticizers and secondary plasticizers. Primary plasticizers are required to gel a polymer rapidly in the normal processing temperature range. Example: Monomeric Di and Tri esters, Di octyl Phthalate etc. Secondary plasticizers have lower gelatin capacity and limited compatibility with the polymers. Example: Petroleum derivatives consist of aliphatic, Aromatic or chlorinated Hydrocarbon.
- Plasticizers also increases the flexibility of polymeric films material and impart good low temperature performance considerably, give good weathering resistance and improved chemical resistances thereby increasing the life of the PVC end products.
- leaching out i.e. Migration, which is a non-compliance with food content regulations, and Evaporation of plasticizers during processing. This obviated from the use of plasticizer containing PVC in the pharmaceutical and food industry.
- Additives on the other hand are widely used in thermoplastic and thermosetting polymers to adjust the handling, processing the properties.
- Additives improve or modify the mechanical properties, increase the resistance to degradation during processing or application, improve the appearance of the product and improve the process ability and productivity.
- Examples include: Mineral particles, Fibres, Pigments, 1,4 Benzenedicarboxylic acid, Calcium carbonate, Aluminium silicate, Fatty acids, Carbon black, Ethylene methyl acrylate co polymer, Adipate, Antimony Oxide, 4,4-Isopropylidenediphenol alkyli, Methylitin 2-mercaptoethyloleate sulfide, Phosphorus acid and Pentaerythritol and the like.
- additives and plasticizers result in polymeric film having certain heavy metals like lead, cadmium, and mercury and hexavalent chromium being present.
- the level of Heavy metal in polymeric material is determined by means of Atomic Absorption Spectrophotometer. The level of the heavy metal in polymeric film should not be exceeding 100 ppm by weight. It is known that within the plastic layer particles tends to migrate. The migration of particles in plastic material, which contain additives or other processing aids, which can contaminate the ingredient and even harm the consumer of the product. Universally certain migration limits (10 mg/dm 2 or 60 ppm.) have been specified for the usage of plastic material for food & drug packaging.
- VCM Vinyl Chloride Monomer
- the object of the invention is to provide a metallized container system.
- the container system which includes a blister formation which can contain a pharmaceutical product under controlled conditions of opacity and moisture.
- Yet another object of the invention is to provide a metallized PVC blister pack system for pharmaceutical and healthcare products which gives better control for transmission of water vapour and light.
- Yet another object of the invention is to provide a metallized plastic container system for pharmaceutical and healthcare products, which has means to facilitate visual inspection of the packed product within and at the same time moisture egress and ingress into the container and its opacity can be controlled.
- a container for pharmaceutical packaging which has inherent properties for the protection of pharmaceutical products selectively from light, including ultra violet light and moisture.
- Another object of this invention is to provide a metallized blister-packaging container with semitransparent to opaque appearance, through which a packed product may be visible.
- Another object is to provide a metallized container so that an online NFD (non filled detection) system can be used on the complete packed system also.
- NFD non filled detection
- Yet another object of this invention is to provide a container, which provides an anti- counterfeit solution since the metallizing cannot easily imitated by counterfeiters.
- Yet another object of this invention is to provide a container having better aesthetics and metallic lustre and therefore creates a brand identity.
- Still another object of this invention is to provide a container, which can be formed on both rotary, vacuum forming and flat, pressure forming thermoforming and cold forming machines with high productivity.
- Yet another object of this invention is to provide a metallized container that is formed by thermoforming or cold forming process.
- a container for packaging pharmaceutical products said container consisting of a lid element and a base element, sealingly securable to each other, the base comprising a composite multilayer film having a substrate of thickness 100 to 1000 microns of pharmaceutical grade polyvinyl chloride, at least one metallized layer of effective thickness of 0.005 to 2 microns provided at least on one side of the said substrate and optionally at least one 0.001 to 250 microns thick pharmaceutical grade predominantly organic layer provided at least on one side of the substrate to form a composite multi layer film having an opacity ranging from 90% to 100%, said base having at least one formation for holding a pharmaceutical product, said formation having a controllable opacity of 99.9% to 10% and a controllable MVTR between 0.01 to 15 g/m 2 /day .
- the metallized layer is formed on the substrate or is applied on the substrate.
- the metallized layer is formed on the substrate by at least one of the processes of metallization consisting of vacuum deposition, indirect metallization, electro less plating, electrolytic plating and lacquer painting.
- the metallized layer consists of at least one metal selected from a group of metals consisting of Aluminium, Copper, Silver, Gold, Brass and Bronze.
- the additional organic layer is provided on the polyvinyl chloride substrate on the non metallized side.
- the additional organic layer is provided on the polyvinyl chloride substrate metallized side.
- the organic layer is provided both on the metallized as well as the non metallized side of the polyvinyl chloride substrate.
- the organic layer consists of at least one substances selected from a group of substances consisting of polyvinylidine chloride, LDPE, HDPE, cyclic-olefin copolymer, collared or colourless lacquer and silicone.
- the at least one organic layer provided is laminated over the metallized layer using a tie layer, typically of polyvinylidine chloride.
- the at least one organic layer is a cast metallized polyvinyl chloride.
- the at least one formation in the base is formed by thermoforming.
- the at least one formation in the base is formed by cold forming.
- the lid element is a base element, with the formations in the lid and the base element being aligned with each other.
- the lid element is a base element, with the formations in the lid and the base element are not aligned with each other.
- the at least one additional organic layer is a silicone layer.
- the said additional organic layer is a collared or colourless lacquer layer.
- the opacity of the container can be controlled selectively for light of different wave lengths, particularly, UV light. In another embodiment the opacity of the container can be controlled selectively for light of a particular wavelength.
- the said additional organic layer is a collared lacquer permitting light of only a predetermined wavelength to pass through the layer.
- the metallized layer may be so provided as to permit only light of predetermined wavelengths to be transmitted thereto.
- invention provides a formed container having a polymer/metallic combination, its position in the multi layered structure & the individual layer thickness that provide synergy to achieve optimum & coherent functional qualities in the final composite container & metallizing effect on the substrate film by deposition of the metal layer on the base or by lamination of commonly available metallized thin films or regular 0.25 to 16 microns PVC films & various shades of metallized film by applying coloured lacquer on the top of the metallized film.
- Each polymeric substance is known for its diverse physical characteristic properties & hence while forming a multi-layered structure, synergy of these properties is very important to impart cohesiveness to the final film.
- the properties like thermal stability, elongation characteristics, flexibility, yield; seal ability, tensile strength, impact resistance, gloss, transparency & the barrier properties are characteristics of individual polymer films. This property, in turn, influences the functional qualities packaging aesthetics, cost, protection level, sealing integrity etc.
- This invention teaches the usage of a metallized pharmacy grade PVC blister container having moisture and light control features for pharmaceutical packaging.
- this invention envisages a container structure having high to medium barrier multi layer base wall being a viable alternative for high cost polymeric / aluminium structures.
- the base element of the container developed comprises a multi layered structure having an inner layer (Layer coming in contact with the range substance which is packed) made up of Poly vinyl chloride (PVC) having a thickness range between 100 to 1000 microns.
- PVC Poly vinyl chloride
- This PVC film is coated with a fine metallic deposition, typically of Aluminium in the range of
- the container envisaged in accordance with this invention has a base element having thickness above 100 micron and thin metallized films of PVC, CPP, PET or BOPP are laminated onto the PVC film of higher thickness.
- the metallized layer may have thickness varying from 0.005 to 2 microns.
- PVdC Polyvinylidine chloride
- LDPE Olefins
- HDPE Olefins
- COC Cyclic olefin copolymer
- the packaging film for the base element of the container is formed in two ways.
- the substrate PVC surface is in contact with the packed material & also will be in contact with the enclosing (lidding film/foil) with metallized film secured to subsequent polymeric layers by either lamination, coating or co-extrusion process preferably by using an adhesive tie layer of PVdC having thickness range between 0.01 micron to 100 micron.
- the metallized surface is exposed to the atmosphere with subsequent polymer coating done on the non-metallized side, which comes in contact with the material and the lidding foil for blister packing application.
- These composite films may typically be given a silicone coating for enhancing the barrier property.
- the thickness of the organic layer also significantly determines the barrier properties. Mildly barrier to very barrier films are produced by coating 0 microns to 100 microns respectively. The flexibility and drawability of the film is improved by lamination of the film with LDPE. The basic strength of the film is, improved by using higher thickness PVC film for metallization. The opacity and barrier property of the film to moisture and light are improved by increasing the thickness of the metallic layer.
- Moisture uptake by pharmaceutical products as a result of exposure to high relative humidity (RH) affects the chemical or physical stability of moisture-sensitive products.
- Alendronate Stable for 3 months at 40 degrees C and 75% Relative Humidity
- Amlodipine Disintegrates in the presence of small amounts of water
- Ciprofloxacin May absorb a small amount of water over time.
- Loperamide Moisture sensitive and can change colour
- Moisture ingress into the well-sealed primary packages occurs primarily via permeation and diffusion through the container wall.
- compositions are typically packaged in plastic bottles, thermoformed plastic blisters, or cold-formed aluminium blisters.
- MVTR Magnetic Transmission Rate
- 15 MVTR is also a measure of breathability and is also known as WVTR "Water Vapour Transmission Rate.
- Packaging material with an optimum MVTR is critical in achieving the desired quality, safety, efficacy and shelf-life for the products.
- UV light is not only a form of packets of energy [photons] but also a form of electromagnetic radiation and different components of light have different wave lengths.
- visible light which occupies only a very small portion of the electromagnetic spectrum is radiation in the range of 410 to 680 nanometers.
- Ultra violet light which is known to be more degrading is light with wavelengths shorter than 400 nanometers. In fact ultra violet light covers a span of 380 to 100 nanometers. Of this, UV light in the range of 100 to 280 nanometers, peaking at 265 nanometers has strong degrading activity.
- the photo degradation of drugs refers to complex photoreactions in the pharmaceutical product.
- Toxicity is a common result of the interaction of sunlight with pharmaceutical agents transported in the blood system or applied topically. The probability that the pharmaceutical product will undergo a photosensitization reaction is directly proportional to its lifetime.
- Nifedipine and molsidomine tablets are extremely photolabile drug preparations, even at cool room light.
- the light spectrum responsible for photo degradation moves towards the long- wavelength range corresponding to the bathochromic shift of light absorption in the solid state.
- nifedipine tablets In the case of nifedipine tablets, incident light up to 500 nm, especially in the range between 400-420 nm, is degrading. Therefore light in this range must be blocked, typically violet to blue light. Molsidomine tablets, on the other hand, are affected only by ultraviolet light, but not by visible light. In both cases light penetrates less than 1 mm into the tablets. For nifedipine tablets the exact penetration depth can be determined due to the discolouration of the drug substance upon irradiation and Particular features of photolabile substances in tablets.
- This invention teaches that by providing at least one metallized layer in the base element of the container either alone or in combination with at least one suitable organic layer with or without a pigment, the opacity of the base element can be finely controlled to selectively reflect a portion of the light incident on the container and at the same time, filter degrading incident radiation.
- the mechanism of the metallized layer either alone or in combination with an organic layer and by varying the thickness of the base PVC substrate, means for controlling the MVTR of the container are
- Metallization on thin films are generally done by vaporizing Aluminium in a vacuum chamber under very high vacuum. The Aluminium vapour will be then condensed on to the film surface, which forms a thin Aluminium layer. A single monoatomic layer on the surface is oxidised to aluminum oxide and protects and stabilizes the aluminum layer.
- Metallization imparts additional water vapour, gas and UV barrier properties to the film.
- the metallization not only protects the pharmaceutical product but also the substrate from UV degradation.
- the aluminium particles in the metallized layer help to reflect UV light in the band of 200 to 380 nanometers.
- Applying an organic layer over the metallized layer further protects not only the metallized layer but also the PVC substrate.
- the invention provides a container having a base element of polymer/metallic combination, its position in the multi layered structure & the individual layer thickness that provide synergy to achieve optimum & coherent functional qualities in the multi layered base element & Metallizing effect on the thicker film by lamination of commonly available metallized thin films on regular 100-1000 micron PVC films & various shades of metallized film by applying coloured lacquer on the top of the metallized film.
- the unique combination of a metallized layer and a coloured lacquer/organic layer not only provides semi transparency to the formation in the final container, but allows for fine control of the light being transmitted through the film to prevent photo degradation of the product.
- the MVTR of the film at the site of the formations is also controlled depending upon the inherent characteristic of the product required to be packed in the container.
- Incident light is typically controlled in two ways: the metallized layer reflects a portion of the incident light even in the deformed configuration. At the same time by selectively providing one or more pigments in the organic layer, either by itself or in combination with the metallized layer, light of predetermined wavelengths is filtered out.
- Each polymeric substance is known for its diverse physical characteristic properties & hence while forming a multi-layered structure, synergy of these properties is very important to impart cohesiveness to the final film.
- the properties like thermal stability, elongation characteristics, flexibility, yield, seal ability, tensile, strength, impact
- the packaging container can be thermoformed or cold formed.
- the substrate PVC surface is in contact with the packed material & also will be in contact with the enclosing (lidding film/foil) with metallized film secured to subsequent polymeric layers by either lamination, coating or co-extrusion process preferably by using an adhesive tie layer of PVdC having thickness range between 0.01 micron to 100 micron.
- the metallized surface is exposed to the atmosphere with subsequent polymer coating done on the non-metallized side, which comes in contact with the material and the lidding foil for blister packing application.
- the composite films may typically be given a silicone coating for enhancing the barrier property.
- the metallization of the PVC film is done by vacuum deposition or sputtering process or electrolysis process. Thickness of metallization deposition can be determined as a function of electrical resistivity (ohms) of the metallized surface or in certain cases its optical density. Additional layers of polymeric material such as olefins are applied by lamination process. An organic layer such as a PVdC layer is formed by dispersion coating method on the metallized PVC film. Lamination and coating could be done in either on the metallized side or the non-metallized side of PVC.
- the thickness of the organic layer determines the moisture barrier properties. Mildly barrier to very moisture barring films can be selectively produced. The flexibility and drawability of the film is improved by lamination of the film with other materials such as LDPE. The basic strength of the film is, improved by using higher thickness PVC film for metallization. The opacity and barrier property of the film is improved by increasing the thickness of the metallic layer and by adding pigments in the organic layer, typically lacquers. Thus for instance if violet light is required to be blocked then typically a lacquer with a sunset yellow pigment can
- Moisture vapour transmission rate is the measure of the permeability of water vapour through the film/package under specified conditions of temperature & humidity and is denoted in gm/(m 2 . 24 hr.) at 38 0 C & 90% RH.
- Moisture barrier property and pack integrity of packaging was determined with accurate MVTR measurement.
- Optimum packaging selection, protection level of composite designs, package configuration, closure efficiency of seal/cap design & shelf life prediction of the packed product at various , climatic conditions all can be accurately carried out with precise measurement of MVTR. In the below given examples the testing was done using MOCON Permetan MVTR measuring instrument. The moisture that permeates through the film is carried by the carrier gas and analysed by the IR modulated detector giving accurate and fast results of MVTR.
- Opacity of the container was checked using a Spectrophotometer [make X rite] which indicates relative opacity of plastic film, with a single pass of the light source through the material, the system measures relative light transmission on a scale of 0 to 100 Opacity Units, representing perfectly transparent to purely opaque materials, respectively using a visible light source and a photoelectric detector.
- This instrument was also used to determine the colour variation by measuring I 5 a, b values which denotes the lighter and darker shades, bluer and yellower shades, and greener and reder shades.
- the flat film sample was first kept in a black ground and the light reflected from the sample was determined. Further the sample was kept on a white back ground and the reflected light was determined . Further reading were taken on the reflection from the white back ground without the sample. Opacity of the film was then calculated based on the analysis of these readings.
- the instrument was also used to measure L, a and b values and therefore calculations were obtained for the transmitted blocked and reflected wave lengths of light from the sample.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.05 micron.
- a 10 micron PVDC layer was applied on the PVC film by dispersion method on non metallized side.
- Opacity of the film was 97.04 % measured before blister formation.
- MVTR of the film was 0.53 g/m /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 33.78 % measured after blister formation.
- MVTR of the film was 3.11 g/m 2 /day measured after blister formation.
- An analgesic formulation of Paracetamol in tablet dosage form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 200 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.04 micron.
- a 20 micron PVDC layer was applied on the PVC film by dispersion method on non metallized side.
- Opacity of the film was 96.14 % measured before blister formation.
- MVTR of the film was 0.47 % measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- MVTR of the film was 2.46 g/m 2 /day measured after blister formation.
- An analgesic formulation of Paracetamol in tablet dosage form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.04 micron.
- a 35 micron PVDC layer was applied on the PVC film by dispersion method on non metallized side and metallized side.
- Opacity of the film was 96.14 % measured before blister formation.
- MVTR of the film was 0.34 g/m 2 /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 25.9 % measured after blister formation.
- MVTR of the film was 1.64 g/m 2 /day measured after blister formation.
- An analgesic formulation of Paracetamol in tablet dosage form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 200 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.04 micron.
- a lO micron PVDC layer was applied on the PVC film by dispersion method on non metallized side.
- a 2 micron colourless lacquer was applied on
- Opacity of the film was 96.14 % measured before blister formation.
- MVTR of the film was 0.62 g/m 2 /day measured before blister formation.
- Opacity of the film was 25.9 % measured after blister formation.
- MVTR of the film was 3.54 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 300 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.04 micron.
- a 23 micron PVDC layer was applied on the PVC film by dispersion method on non metallized side.
- a 3 micron red coloured lacquer was applied on PVC film on metallized side.
- Opacity of the film was 96.29% measured before blister formation.
- MVTR of the film was 0.42 g/m /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 26.95 % measured after blister formation.
- MVTR of the film was 2.09 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- the film effectively blocked the transmission of light having wave lengths for violet, indigo and blue light.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.05 micron.
- a 10 micron LDPE layer was applied on the PVC film by lamination method on non metallized side.
- Opacity of the film was 97.09 % measured before blister formation.
- MVTR of the film was 0.71 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 34.4 % measured after blister formation.
- MVTR of the film was 4.97 g/m 2 /day measured after blister formation.
- a set of Ethambutol hydrochloride formulation in tablet form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 350 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron. 55 microns PVdC layer is applied by reverse gravure technique and 30 micron LDPE layer was applied on the PVC film by lamination method on non metallized side.
- Opacity of the film was 99.89 % measured before blister formation.
- MVTR of the film was 0.20 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 69.40 % measured after blister formation.
- MVTR of the film was 1.0 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 150 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.03 micron.
- a 15 micron LDPE layer was applied on the PVC film by lamination method on non metallized side and metallized side.
- Opacity of the film was 95.31% measured before blister formation.
- MVTR of the film was 1.16 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 21.34 % measured after blister formation.
- MVTR of the film was 7.95 g/m 2 /day measured after blister formation.
- An analgesic formulation of Paracetamol in tablet dosage form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 400 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron.
- a 25 micron LDPE layer was applied on the PVC film by lamination method on non metallized side " .
- a 23 -micron PVdC is coated on PVC film on metallized side.
- Opacity of the film was 99.86 % measured before blister formation.
- MVTR of the film was 10.29 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 65.2 % measured after blister formation.
- MVTR of the film was 1.62 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 200 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron.
- a 10 micron LDPE layer was applied on the PVC film by lamination method on non metallized side.
- a 2 micron green collared lacquer was applied on PVC film on metallized side.
- Opacity of the film was 99.89 % measured before blister formation.
- MVTR of the film was 0.49 g/m 2 /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 69.5 % measured after blister formation.
- MVTR of the film was 3.98 g/m /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.05 micron.
- a 10 micron HDPE layer was applied on the PVC film by lamination method on non metallized side.
- Opacity of the film was 97.24 % measured before blister formation.
- MVTR of the film was 0.70 g/m /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 36.23 % measured after blister formation.
- MVTR of the film was 4.90 g/m /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 300 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.04 micron.
- a 20 micron HDPE layer was applied on the PVC film by lamination method on non metallized side.
- Opacity of the film was 96.54 % measured before blister formation.
- MVTR of the film was 0.78 g/m 2 /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 28.90 % measured after blister formation.
- MVTR of the film was 4.85 g/m 2 /day measured after blister formation.
- a set of Ethambutol hydrochloride formulation in tablet form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 150 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.06 micron.
- a 15 micron HDPE layer was applied on the PVC film by lamination method on non metallized side and metallized side.
- Opacity of the film was 98.24 % measured before blister formation.
- MVTR of the film was 0.65 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 56.82 % measured after blister formation.
- MVTR of the film was 5.11 g/m 2 /day measured after blister formation.
- a set of Ethambutol hydrochloride formulation in tablet dosage form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 200 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.06 micron.
- a 10 micron HDPE layer was applied on the PVC film by lamination method on non metallized side.
- a 2 micron colourless lacquer was applied on
- Opacity of the film was 98.14 % measured before blister formation.
- MVTR of the film was 0.63 g/m 2 /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 53.76 % measured after blister formation.
- MVTR of the film was 4.78 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 200 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.06 micron.
- a 10 micron HDPE layer was applied on the PVC film by lamination method on non metallized side.
- a 5 micron violet coloured lacquer was applied on PVC film on metallized side.
- Opacity of the film was 98.39 % measured before blister formation.
- MVTR of the film was 0.63 g/m 2 /day measured before blister formation.
- the said film was deformed on a flat bed blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 62.1% measured after blister formation.
- MVTR of the film was 4.78 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a
- the base effectively blocked the transmission of red light through it.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.06 micron.
- a 100 micron cyclic-olefm copolymer layer was applied on the
- Opacity of the film was 97.94 % measured before blister formation.
- MVTR of the film was 0.35 g/m 2 /day measured before blister formation.
- the said film was deformed on a flat bed blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 48.54% measured after blister formation.
- MVTR of the film was 1.68 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 150 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.06 micron.
- a 20 micron cyclic-olefm copolymer layer was applied on the
- Opacity of the film was 97.94 % measured before blister formation.
- MVTR of the film was 0.57 g/m 2 /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 48.54 % measured after blister formation.
- MVTR of the film was 3.85 g/m 2 /day measured after blister formation.
- a set of Ethambutol hydrochloride formulation in tablet form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- a 150 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.06 micron.
- a 20 micron cyclic-olefin copolymer layer was applied on the
- Opacity of the film was 97.94 % measured before blister formation.
- MVTR of the film was 0.57 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 48.54 % measured after blister formation.
- MVTR of the film was 3.85 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 200 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.06 micron.
- a 190 micron cyclic-olefin copolymer layer was applied on the
- PVC film by lamination method on non metallized side was laminated on non metallized side.
- a 4 micron colourless lacquer was applied on PVC film on metallized side.
- Opacity of the film was 97.94 % measured before blister formation.
- MVTR of the film was 0.25 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 48.54 % measured after blister formation.
- MVTR of the film was 1.09 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 200 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.06 micron.
- a lO micron cyclic-olefin copolymer layer was applied on the
- PVC film by lamination method on non metallized side was laminated on non metallized side.
- a 3 micron red coloured lacquer was applied on PVC film on metallized side.
- Opacity of the film was 98.09 % measured before blister formation.
- MVTR of the film was 0.59 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 52.35 % measured after blister formation.
- MVTR of the film was 4.18 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- the container effectively blocked light in the wavelength below 650 nanometre from reaching the packed products.
- a 150 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.05 micron.
- a 35 micron PVDC layer was applied on the PVC film by dispersion method on non metallized side.
- Opacity of the film was 97.04 % measured before blister formation.
- MVTR of the film was 0.33 g/m 2 /day measured before blister formation.
- Opacity of the film was 33.80 % measured after blister formation.
- MVTR of the film was 1.67 g/m 2 /day measured after blister formation.
- a set of highly sensitive multi vitamin capsules form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron.
- a 20 micron PVDC layer was applied on the PVC film by dispersion method on non metallized side.
- Opacity of the film was 99.74% measured before blister formation.
- MVTR of the film was 0.33 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 63.9 % measured after blister formation.
- MVTR of the film was 1.94 g/m 2 /day measured after blister formation.
- a set of highly sensitive multi vitamin capsules form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron.
- a 15 micron PVDC layer was applied on the PVC film by dispersion coating method on non metallized side and metallized side.
- Opacity of the film was 99.74 % measured before blister formation.
- MVTR of the film was 0.36 g/m 2 /day measured before blister formation.
- Opacity of the film was 63.9 % measured after blister formation.
- MVTR of the film was 2.22 g/m 2 /day measured after blister formation.
- a set of highly sensitive multi vitamin capsules dosage form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 100 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.01 micron.
- a 10 micron PVDC layer was applied on the PVC film by dispersion method on non metallized side.
- a lO micron colourless lacquer was applied on
- Opacity of the film was 93.44 % measured before blister formation.
- MVTR of the film was 1.20 g/m /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 15.24 % measured after blister formation.
- MVTR of the film was 5.5 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 100 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.008 micron.
- a 70 micron PVDC layer was applied on the PVC film by dispersion method on non metallized side.
- a 4 micron blue coloured lacquer was applied on PVC film on metallized side.
- MVTR of the film was 0.26 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 15.29 % measured after blister formation.
- MVTR of the film was 1.08 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 150 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.009 micron.
- a 25 micron LDPE layer was applied on the PVC film by lamination method on non metallized side.
- Opacity of the film was 93.48 % measured before blister formation.
- MVTR of the film was 2.41 g/m 2 /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 15.32 % measured after blister formation.
- MVTR of the film was 11.83 g/m 2 /day measured after blister formation.
- a set of Ethambutol hydrochloride formulation in tablet form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.04 micron.
- a 20 micron LDPE layer was applied on the PVC film by lamination method on non metallized side.
- MVTR of the film was 0.83 g/m 2 /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 26.59 % measured after blister formation.
- MVTR of the film was 5.41 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.06 micron.
- a 30 micron LDPE layer was applied on the PVC film by lamination method on non metallized side and metallized side.
- Opacity of the film was 98.09 % measured before blister formation.
- MVTR of the film was 0.60 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 52.35 % measured after blister formation.
- MVTR of the film was 4.26 g/m 2 /day measured after blister formation.
- a set of highly sensitive multi vitamin capsules form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 100 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron.
- a 10 micron LDPE layer was applied on the PVC film by
- Opacity of the film was 99.6 % measured before blister formation.
- MVTR of the film was 0.52 g/m 2 /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 72.80 % measured after blister formation.
- MVTR of the film was 4.6 g/m 2 /day measured after blister formation.
- One set of medium sensitive herbal formulation in capsule form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- the blister formation had a hazy appearance and effectively attenuated the the transmission of visible light through out the visible spectrum.
- a 100 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.03 micron.
- a 40 micron LDPE layer was applied on the PVC film by lamination method on non metallized side.
- An 8 micron golden coloured lacquer was applied on PVC film on metallized side.
- Opacity of the film was 95.84 % measured before blister formation.
- MVTR of the film was 1.17 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 24.04 % measured after blister formation.
- MVTR of the film was 8.18 g/m 2 /day measured after blister formation.
- One set of medium sensitive herbal formulation in capsule form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a
- the blister formation had a golden haze and effectively attenuated visible light through out the visible light spectrum particularly blue green light wave lengths.
- a 150 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.05 micron.
- a lO micron HDPE layer was applied on the PVC film by lamination method on non metallized side.
- Opacity of the film was 97.24 % measured before blister formation.
- MVTR of the film was 0.76 g/m 2 /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 36.23 % measured after blister formation.
- MVTR of the film was 5.89 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron. 100 microns PVdC is applied by air knife coating technique on the metallized side and 20 micron HDPE layer was applied on the PVdC layer by lamination method on non metallized side.
- Opacity of the film was 99.7 % measured before blister formation.
- MVTR of the film was 0.14 g/m 2 /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 64.90 % measured after blister formation.
- MVTR of the film was 0.65 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron.
- a 40 micron HDPE layer was applied on the PVC film by lamination method on non metallized side and metallized side.
- Opacity of the film was 99.78 % measured before blister formation.
- MVTR of the film was 0.46 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 72.70 % measured after blister formation.
- MVTR of the film was 3.41 g/m 2 /day measured after blister formation.
- a set of Ethambutol hydrochloride formulation in dosage form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 100 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron.
- a 10 micron HDPE layer was applied on the PVC film by lamination method on non metallized side.
- a lO micron colourless lacquer was applied on
- Opacity of the film was 99.62 % measured before blister formation.
- MVTR of the film was.0.52 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 62.0 % measured after blister formation.
- 38 MVTR of the film was 4.56 g/ni 2 /day measured after blister formation.
- One set of medium sensitive herbal formulation in capsule form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 100 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.01 micron.
- a 30 micron HDPE layer was applied on the PVC film by lamination method on non metallized side.
- a 3 micron golden coloured lacquer was applied on PVC film on metallized side.
- Opacity of the film was 94.19 % measured before blister formation.
- MVTR of the film was 2.43 g/m 2 /day measured before blister formation.
- the said film was formed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 17.1 % measured after blister formation.
- MVTR of the film was 12.69 g/m /day measured after blister formation.
- One set of medium sensitive herbal formulation in capsule form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken capsule in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- the blister formation had a light golden haze and effectively attenuated visible light through out the visible light spectrum particularly blue green light wave lengths.
- a 150 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.05 micron.
- a lO micron cyclic-olefm copolymer layer was applied on the
- Opacity of the film was 97.04 % measured before blister formation.
- MVTR of the film was 0.71 g/m 2 /day measured before blister formation.
- Opacity of the film was 33.8 % measured after blister formation.
- MVTR of the film was 5.07 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron.
- a 20 micron cyclic-olefm copolymer layer was applied on the
- Opacity of the film was 99.74 % measured before blister formation.
- MVTR of the film was 0.43 g/m /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 63.9 % measured after blister formation.
- MVTR of the film was 2.95 g/m /day measured after blister formation.
- a set of Ethambutol hydrochloride formulation in tablet form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron.
- a 15 micron cyclic-olefm copolymer layer was applied on the
- PVC film by lamination method on non metallized side and metallized side.
- Opacity of the film was 99.74 % measured before blister formation.
- MVTR of the film was 0.44 g/m 2 /day measured before blister formation.
- Opacity of the film was 63.8 % measured after blister formation.
- MVTR of the film was 3.13 g/m 2 /day measured after blister formation.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 100 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron.
- a lO micron cyclic-olefin copolymer layer was applied on the
- PVC film by lamination method on non metallized side was laminated on non metallized side.
- a lO micron colourless polyester based lacquer was applied on PVC film on metallized side.
- Opacity of the film was 99.7 % measured before blister formation.
- MVTR of the film was 0.50 g/m 2 /day measured before blister formation.
- the said film was deformed on a tablet blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 60.8 % measured after blister formation.
- MVTR of the film was 4.0 g/m /day measured after blister formation.
- a set of Ethambutol hydrochloride formulation in tablet form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 100 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.08 micron.
- a lO micron cyclic-olefin copolymer layer was applied on the PVC film by lamination method on non metallized side.
- a lO micron red coloured lacquer was applied on PVC film on metallized side.
- Opacity of the film was 99.73 % measured before blister formation.
- MVTR of the film was 0.50 g/m 2 /day measured before blister formation.
- the said film was deformed on a blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 63.20 % measured after blister formation.
- MVTR of the film was 4.0 g/m 2 /day measured after blister formation.
- a set of Ethambutol hydrochloride formulation in tablet form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- the 1 blister formation transmitted red light had a red haze but completely blocked violet light.
- a 250 micron PVC film was Aluminium metallized by vacuum deposition method with thickness of 0.005 micron.
- Opacity of the film was 93.0 % measured before blister formation.
- MVTR of the film was 2.53 g/m 2 /day measured before blister formation.
- the said film was cold formed in a pressure forming flat bed blister packing machine, wherein metallized side was facing outside the pack and not touching the packed product.
- Opacity of the film was 14.2 % measured after blister formation.
- MVTR of the film was 10.38 g/m /day measured after blister formation.
- a set of Ethambutol hydrochloride formulation in tablet form was packed in each blister with 25 micron VMCH coated Aluminium as the lidding foil.
- Each blister pack was scanned by visual inspection and by automated laser scanner for empty blisters and broken tablet in blisters. An accuracy of 100 % was achieved over a quantity of about 5000 blister packs, by both methods of inspection, which clearly indicated suitability of metallized PVC for blister pack.
- a 400 micron PVC film having 0.05 micron thick aluminium metallized layer obtained by vacuum deposition method was thermoformed into a blister container.
- the opacity of the original film was 97.04 and MVTR was 0.64 g/m 2 /day.
- the opacity of the container was 33.8 %.
- MVTR of the container was 4.04 g/m 2 /day.
- a 250 micron PVC film having 0.10 micron thick aluminium metallized layer obtained by vacuum deposition method was further coated with a 35 micron thick layer of PVdC.
- the opacity of the film was 99.82 % and the MVTR was 0.23 g/m 2 /day.
- the film was then cold formed in a pressure forming flat bed machine into a container.
- the opacity of the container was 79 %.
- MVTR of the container was 1.34 g/m 2 /day.
- a 300 micron PVC film having 0.50 micron thick aluminium metallized layer obtained by vacuum deposition method.
- the opacity of the film was 99.94 % and the MVTR was 0.09 g/m /day.
- the film was then cold formed in a pressure forming blister machine.
- the opacity of the container was 82 %.
- MVTR of the container was 0.82 g/m 2 /day.
- the opacity of the film was 99.97 % and the MVTR was 0.04 g/m 2 /day.
- the film was then formed in to blister form of container using a pressure forming blister machine. The opacity of the blister thus formed was 96.4 %.
- MVTR of the container was 0.41 g/m 2 /day.
- a 600 micron PVC film having 1.5 micron thick aluminium metallized layer obtained by vacuum deposition method in multiple passes.
- the opacity of the film was 100 % and the MVTR was 0.02 g/m /day.
- the film was then formed in to blister form of container using
- the opacity of the blister thus formed was 99.4 %.
- MVTR of the container was 0.28 g/m 2 /day.
Landscapes
- Chemical & Material Sciences (AREA)
- Composite Materials (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Packages (AREA)
- Laminated Bodies (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Wrappers (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1612MU2005 | 2005-12-23 | ||
| PCT/IN2006/000498 WO2007072505A2 (en) | 2005-12-23 | 2006-12-22 | Metallized packaging blister container |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1979244A2 true EP1979244A2 (en) | 2008-10-15 |
| EP1979244A4 EP1979244A4 (en) | 2010-07-21 |
Family
ID=38188326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP06848703A Ceased EP1979244A4 (en) | 2005-12-23 | 2006-12-22 | Metallized packaging blister container |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1979244A4 (en) |
| AR (1) | AR058743A1 (en) |
| BR (1) | BRPI0621087A2 (en) |
| MX (1) | MX2008006380A (en) |
| TW (1) | TW200733950A (en) |
| WO (2) | WO2007072494A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9150119B2 (en) | 2013-03-15 | 2015-10-06 | Aesynt Incorporated | Apparatuses, systems, and methods for anticipating and delivering medications from a central pharmacy to a patient using a track based transport system |
| US9511945B2 (en) | 2012-10-12 | 2016-12-06 | Aesynt Incorporated | Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility |
| CN113493007A (en) * | 2020-03-18 | 2021-10-12 | 乌尔曼包装系统有限责任及合伙两合公司 | Sealing device and method |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2033775A1 (en) * | 2007-09-10 | 2009-03-11 | Alcan Technology & Management Ltd. | Thermoformable laminate for blister bottom parts |
| US20110150942A1 (en) * | 2008-06-13 | 2011-06-23 | Natalija Zajc | Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives |
| KR101285091B1 (en) * | 2008-06-24 | 2013-07-17 | 빌케어 리미티드 | Multilayer film |
| RS53782B1 (en) | 2008-10-01 | 2015-06-30 | Immatics Biotechnologies Gmbh | TUMOR-ASSOCIATED PEPTIDES PREPARED AND ANTI-CHANGE RESPONSE FOR GLIOBLASTOMA (GBM) AND OTHER CANCER TREATMENTS |
| CA2793470A1 (en) | 2010-03-18 | 2011-09-22 | Medcomb Holding Aps | A disposable rigid container for pharmaceutical compositions |
| DK2758022T3 (en) | 2011-09-21 | 2016-02-15 | Medcomb Holding Aps | Rigid disposable container for pharmaceutical compositions |
| DE102014015027A1 (en) * | 2014-10-09 | 2016-04-14 | Kostal Kontakt Systeme Gmbh | Electrical connector assembly |
| US20170105287A1 (en) * | 2015-10-12 | 2017-04-13 | Tyco Electronics Corporation | Process of Producing Electronic Component and an Electronic Component |
| DE102016122818B4 (en) * | 2016-11-25 | 2019-11-28 | Waldemar Schmidt | Co-extruded PVC food packaging film and process for its production |
| JP2020532720A (en) * | 2017-08-31 | 2020-11-12 | バイオファイア・ダイアグノスティクス,リミテッド・ライアビリティ・カンパニー | Assay device and how to use it |
| DE102018206381A1 (en) * | 2018-04-25 | 2019-10-31 | Huhtamaki Flexible Packaging Germany Gmbh & Co. Kg | Use of a COC-containing flexible film laminate for producing a cold-drawn flexible packaging |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4103800A1 (en) * | 1990-09-27 | 1992-04-02 | Helmuth Schmoock | FOIL |
| CH689799A5 (en) * | 1995-11-28 | 1999-11-30 | Alusuisse Lonza Services Ag | Packaging container made of a multilayer composite |
| EP0845350A1 (en) * | 1996-11-29 | 1998-06-03 | Alusuisse Technology & Management AG | Cold formable laminated film |
| US6270869B1 (en) * | 1998-12-02 | 2001-08-07 | Alusuisse Technology & Management Ltd. | Cold formable laminate films |
| EP1048746B1 (en) * | 1999-04-28 | 2005-09-21 | Alcan Technology & Management AG | Method and apparatus for making packages |
| EP1086800A1 (en) * | 1999-09-21 | 2001-03-28 | Alusuisse Technology & Management AG | Method for producing form packages |
| US7017391B2 (en) * | 2002-09-17 | 2006-03-28 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Method for measuring the leaktightness of sealed containers |
| CN2603026Y (en) * | 2003-01-27 | 2004-02-11 | 刘继福 | Cold stamping type plastics-aluminium combined diaphragm for high seal package |
| US7758936B2 (en) * | 2003-09-18 | 2010-07-20 | Boehringer Ingelheim Gmbh | Pharmaceutical blister |
| US7144619B2 (en) * | 2004-02-03 | 2006-12-05 | Naik Praful Ramchandra | Metallized packaging films |
-
2006
- 2006-05-17 WO PCT/IN2006/000167 patent/WO2007072494A1/en not_active Ceased
- 2006-12-22 WO PCT/IN2006/000498 patent/WO2007072505A2/en not_active Ceased
- 2006-12-22 BR BRPI0621087-2A patent/BRPI0621087A2/en not_active Application Discontinuation
- 2006-12-22 EP EP06848703A patent/EP1979244A4/en not_active Ceased
- 2006-12-22 MX MX2008006380A patent/MX2008006380A/en not_active Application Discontinuation
- 2006-12-22 TW TW095148645A patent/TW200733950A/en unknown
- 2006-12-26 AR ARP060105787A patent/AR058743A1/en not_active Application Discontinuation
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9511945B2 (en) | 2012-10-12 | 2016-12-06 | Aesynt Incorporated | Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility |
| US10029856B2 (en) | 2012-10-12 | 2018-07-24 | Aesynt Incorporated | Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility |
| US10315851B2 (en) | 2012-10-12 | 2019-06-11 | Aesynt Incorporated | Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility |
| US10518981B2 (en) | 2012-10-12 | 2019-12-31 | Aesynt Incorporated | Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility |
| US10850926B2 (en) | 2012-10-12 | 2020-12-01 | Omnicell, Inc. | Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility |
| US11694782B2 (en) | 2012-10-12 | 2023-07-04 | Omnicell, Inc. | Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility |
| US9150119B2 (en) | 2013-03-15 | 2015-10-06 | Aesynt Incorporated | Apparatuses, systems, and methods for anticipating and delivering medications from a central pharmacy to a patient using a track based transport system |
| CN113493007A (en) * | 2020-03-18 | 2021-10-12 | 乌尔曼包装系统有限责任及合伙两合公司 | Sealing device and method |
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0621087A2 (en) | 2011-11-29 |
| WO2007072494A1 (en) | 2007-06-28 |
| WO2007072505A3 (en) | 2007-10-25 |
| EP1979244A4 (en) | 2010-07-21 |
| MX2008006380A (en) | 2008-10-17 |
| WO2007072505A2 (en) | 2007-06-28 |
| TW200733950A (en) | 2007-09-16 |
| AR058743A1 (en) | 2008-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7144619B2 (en) | Metallized packaging films | |
| WO2007072505A2 (en) | Metallized packaging blister container | |
| EP3347201B1 (en) | Release of chlorine dioxide gas from medical device packaging film | |
| EP2163379A1 (en) | Resin laminated film for forming blister pack and blister pack | |
| US8329309B2 (en) | Paper-based lidding for blister packaging | |
| CA2359246C (en) | Polyester packaging for nicotine containing product | |
| EP1675722B1 (en) | Pharmaceutical blister package | |
| AU2009229178B2 (en) | Oxygen absorbing plastic structure | |
| EP3524425B1 (en) | A method for providing an chemical resistant film, a film and laminate obtainable therefrom | |
| EP4330156B1 (en) | Recyclable blister package | |
| UA104332C2 (en) | Multi-layer film structure and blister package made from it | |
| JP2004517373A (en) | Tag for detecting opening of package | |
| EP3906154B1 (en) | Product packaging with heat sealable barrier material | |
| RU2453439C2 (en) | Layered material and method of producing said material | |
| US8309005B2 (en) | Method of making a customized packaging film for a pharmaceutical product | |
| US20240416622A1 (en) | High barrier, pvc free, cold forming multilayer blister laminates | |
| Ali et al. | Pharmaceutical packaging | |
| EP0764519A1 (en) | Multi-layer film | |
| WO2023073432A1 (en) | High barrier, pvc free, cold forming multilayer blister laminates | |
| EP3478494A1 (en) | Deep-drawable film | |
| WO2025012800A1 (en) | Mechanically strengthened multilayer, multibarrier, desiccant interlaced cold formable blister laminates, optionally pvc-free | |
| EP3962741B1 (en) | Multi-layer article for storing a product | |
| JPH0457727A (en) | Detecting method for metallic foreign matter | |
| Gomaa et al. | EFFECT OF GAMAA RADIATION ON CHEMICAL, PHYSICAL AND MECHANICAL PROPERTIES OF SOME PLASTICS PACKAGING MATERIALS | |
| BR112016018382B1 (en) | ANTI-SCALPING PHARMACEUTICAL PACKAGING FILM |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20080723 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: B32B 3/26 20060101ALI20100607BHEP Ipc: B65D 65/40 20060101AFI20080702BHEP Ipc: B65D 75/36 20060101ALI20100607BHEP Ipc: A61J 1/03 20060101ALI20100607BHEP Ipc: B32B 27/30 20060101ALI20100607BHEP |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20100618 |
|
| 17Q | First examination report despatched |
Effective date: 20110331 |
|
| DAX | Request for extension of the european patent (deleted) | ||
| APBK | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNE |
|
| APBN | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2E |
|
| APBR | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3E |
|
| APAF | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNE |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
| APBT | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9E |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
| 18R | Application refused |
Effective date: 20141212 |